CLINICAL_TRIALS
trial_result
· 2006-08-02
Clinical Trial Update: A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects [Phase 2]
Summary
A Phase 2 clinical trial evaluating Zemplar (paricalcitol) to increase serum calcium in ICU patients with hypocalcemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Hypocalcemia | Phase 2 | Status: COMPLETED